Product Information
VANACOF DM 18-200-10 MG/15 ML is a brand product labeled by GM Pharmaceuticals, INC, priced at $0.0975 per ML under NDC 58809055508. Its NADAC has been published 311 times since Feb 22, 2017.
VANACOF DM 18-200-10 MG/15 ML
DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
18; 200; 10 mg/15mL; mg/15mL; mg/15mL
Manufacturer
GM Pharmaceuticals, INCNDC
58809055508
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/1/2013
Pharmacological Classes
Price Statistics
The NADAC for VANACOF DM 18-200-10 MG/15 ML has been published 311 times since Feb 22, 2017, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0975 per ML |
|---|---|
| All-time high | $0.1034 (Jul 12, 2017) |
| All-time low | $0.0967 (Nov 20, 2019) |
| 52-week high | $0.0975 |
| 52-week low | $0.0975 |
| Median price | $0.0976 |
| Average price | $0.0983 |
| Largest weekly change | +6.2% (Jun 21, 2017) |
| Weeks tracked | 311 |
| Tracking since | Feb 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GM Pharmaceuticals, INC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANACOF DM 18-200-10 MG/15 ML?
The current National Average Drug Acquisition Cost (NADAC) for VANACOF DM 18-200-10 MG/15 ML, manufactured by GM Pharmaceuticals, INC, is $0.0975 per ML (NDC 58809055508), effective Sep 30, 2026.
How has the price of VANACOF DM 18-200-10 MG/15 ML changed over time?
Over the history we have for it, the NADAC for VANACOF DM 18-200-10 MG/15 ML has declined 4.6%. It has been tracked across 311 weekly CMS publications since Feb 22, 2017.
What are the highest and lowest recorded NADAC prices for VANACOF DM 18-200-10 MG/15 ML?
Since Feb 22, 2017, the NADAC for VANACOF DM 18-200-10 MG/15 ML has ranged from a low of $0.0967 (Nov 20, 2019) to a high of $0.1034 (Jul 12, 2017), with a median of $0.0976 per ML.
Are there cheaper alternatives to VANACOF DM 18-200-10 MG/15 ML?
No other NADAC-published product currently shares the active ingredient and strength of VANACOF DM 18-200-10 MG/15 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VANACOF DM 18-200-10 MG/15 ML?
VANACOF DM 18-200-10 MG/15 ML (NDC 58809055508) is labeled by GM Pharmaceuticals, INC, and CMS classifies it as a brand product.